Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 88,394 | 11,651 | -221,760 | -168,317 | -105,952 |
| Depreciation Amortization | 17,833 | 8,416 | 31,082 | 23,156 | 14,880 |
| Accounts receivable | -332,345 | -135,312 | -21,118 | 4,933 | -1,138 |
| Other Working Capital | -336,742 | -138,389 | -18,913 | 11,114 | 18,413 |
| Other Operating Activity | 397,442 | 166,593 | 89,027 | 37,749 | 29,167 |
| Operating Cash Flow | $-165,418 | $-87,041 | $-141,682 | $-91,365 | $-44,630 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -99,495 | 27,284 | 185,688 | 208,992 | 200,993 |
| PPE Investments | -23,927 | -11,055 | -57,217 | -45,928 | -37,030 |
| Other Investing Activity | 0 | -463 | 0 | -685 | -681 |
| Investing Cash Flow | $-123,422 | $15,766 | $128,471 | $162,379 | $163,282 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 391,107 | N/A | N/A |
| Debt Repayment | -1,014 | -500 | -119,167 | -1,010 | -704 |
| Common Stock Issued | 39,631 | 31,828 | 137,387 | 40,135 | 28,501 |
| Common Stock Repurchased | -61,444 | -49,078 | -25,078 | -16,316 | -4,709 |
| Financing Cash Flow | $-22,827 | $-17,750 | $384,249 | $22,809 | $23,088 |
| Beginning Cash Position | 483,610 | 483,610 | 112,572 | 112,572 | 112,572 |
| End Cash Position | 171,943 | 394,585 | 483,610 | 206,395 | 254,312 |
| Net Cash Flow | $-311,667 | $-89,025 | $371,038 | $93,823 | $141,740 |
| Free Cash Flow | |||||
| Operating Cash Flow | -165,418 | -87,041 | -141,682 | -91,365 | -44,630 |
| Capital Expenditure | -23,927 | -11,055 | -57,217 | -45,928 | -37,030 |
| Free Cash Flow | -189,345 | -98,096 | -198,899 | -137,293 | -81,660 |